Turn Therapeutics Inc. 8-K

What Happened

• Turn Therapeutics, Inc. (TTRX) filed a Current Report on Form 8-K on May 18, 2026 under Item 7.01 to report a Regulation FD disclosure. The company issued a press release on May 18, 2026, and furnished that press release as Exhibit 99.1 to the Form 8-K.

Key Details

• Filing date: May 18, 2026 (Form 8-K).
• Item reported: 7.01 (Regulation FD Disclosure); press release furnished as Exhibit 99.1.
• Exhibits listed: 99.1 (Press Release dated May 18, 2026) and 104 (Interactive XBRL cover page).

Why It Matters

• The Form 8-K notifies investors that Turn Therapeutics has publicly released information via a press release and is making that information available to all investors simultaneously under Regulation FD. Investors should review Exhibit 99.1 to see the substance of the announcement (e.g., any updates on financial results, corporate developments, or operational news) because it may contain details relevant to investment decisions.